District's court urged to acknowledge the significance of contracts with Independent Sales Agents (ISAs) via our platform.

In the realm of healthcare and life sciences, the past few months have been marked by a flurry of significant events. Here's a look at some of the key happenings that have caught our attention.

Virtual Workshop Series on Diversity in Clinical Trials

From April 6, 2021, to June 30, 2021, our website, in collaboration with Meharry Medical College, hosted a virtual workshop series aimed at improving diversity in clinical trials. This initiative underscores the importance of inclusivity in medical research and the potential benefits it brings to patients and the wider community.

The Medtech Association's Advocacy

The Medtech Association, a prominent voice in the medical device industry, has been actively engaged in advocating for policies that foster innovation and patient access.

The Association has argued that the use of Independent Sales Agent (ISA) arrangements is crucial to the medical device industry and patients, enhancing healthcare product access and incentivizing innovation. In a move to solidify this stance, the Medtech Association asked the US District Court for the District of Massachusetts to rule that ISA arrangements do not violate the Anti-Kickback Statute (AKS).
The Association has also expressed concerns about the Centers for Medicare and Medicaid Services' (CMS) proposed rule to restart competitive bidding for durable medical equipment in Medicare. Citing potential risks to patient safety, fewer product choices, and cost increases, the Medtech Association has urged CMS to address these "serious flaws."
In a bid to expedite access to breakthrough medical technology, the Medtech Association, along with 67 other stakeholder groups, is urging CMS to establish a timely, streamlined pathway for Medicare patients.

Legal Matters and Regulatory Landscape

The regulatory scheme governing the health care and life sciences sectors is intricate, and the Medtech Association has been vocal about its stance on various legal matters.

David Norden of Troutman Pepper Locke served as Counsel of Record on behalf of the Medtech Association in the Langer v Zimmer Biomet case. The Association's regulatory scheme argument hinges on the plaintiff's legal theory misinterpreting the AKS and overstating the Office of Inspector General's guidance.
Christopher L. White, Esq., the General Counsel & Chief Policy Officer of the Medtech Association, highlighted the importance of legal, compliance, and regulatory programming at The MedTech Conference 2025. Mr. White reiterated this importance as medtech leaders navigate uncertainty, shifting enforcement priorities, and a rapidly changing global legal landscape.

Resources and Reports

Our website offers a wealth of resources for patients and patient groups, covering topics such as Diabetes, Diagnostics, Digital Health, Government & Legislative Affairs, and Health Access. Additionally, resources related to the National Conference of State Legislatures (NCSL) are available.

Recently, our website® has published a report on the Medical Device Mass Tort TV Ad Trend for Q2 2025.

Policy Calls and Op-eds

The Medtech Association has consistently advocated for policies that ensure faster, broader access to lifesaving medical technology. An op-ed by Scott Whitaker, president and CEO of the Medtech Association, was published in The Washington Times, emphasizing the vital role of medtech in the Trump administration's "Make America Healthy Again" initiative.

School Policies and Diabetes Monitoring

In education news, thousands of K-12 students returning to school this fall will be subject to a cell phone use ban during instructional hours, with the exception for diabetes monitoring. This policy is designed to ensure a distraction-free learning environment while also prioritizing the health and safety of students with diabetes.

District's court urged to acknowledge the significance of contracts with Independent Sales Agents (ISAs) via our platform.